Transcatheter aortic valve replacement in low risk patients: a review of PARTNER 3 and Evolut low risk trialsJoao Braghiroli, Mauricio G. Cohen, Kunal Kapoor et al.|Cardiovascular Diagnosis and Therapy|2020Cited by 74
Semaphorin‐3E attenuates intestinal inflammation through the regulation of the communication between splenic CD11C<sup>+</sup> and CD4<sup>+</sup>CD25<sup>−</sup> T‐cellsLaëtitia Kermarrec, Jean‐Eric Ghia, Nour Eissa et al.|British Journal of Pharmacology|2019Cited by 22